More News

29 Jan 2019 Purdue Pharma L.P. and Alivio Therapeutics Enter into Partnership to Advance ALV-107, a Non-Opioid Interstitial Cystitis/Bladder Pain Syndrome Treatment
24 Jan 2019 Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics for Novel Therapies Targeting RNA-mediated Diseases
24 Jan 2019 Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
24 Jan 2019 CAMP4 Therapeutics Announces Rare Disease Research Collaboration with Alnylam
24 Jan 2019 Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe
24 Jan 2019 B-MoGen Biotechnologies and CytoSen Therapeutics partner on research collaboration to develop next generation Natural Killer Cells for human therapeutics
23 Jan 2019 PeptiDream Announces New Peptide Drug Conjugate (PDC) Discovery Deal with Shionogi
23 Jan 2019 BioNTech to Acquire Antibody Generation Unit of MAB Discovery
23 Jan 2019 PrimeVax Immuno-Oncology Signs Exclusive Worldwide Dengue Virus License with US Army for Cancer Treatments
19 Jan 2019 Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies
19 Jan 2019 Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors, Opening Potential for CAR-T and Other Cellular Medicines in New Settings
18 Jan 2019 Free report: TOP 25 Pharma Groups analyzed for sales, R&D costs, operating and net income by business segments
17 Jan 2019 MD Anderson Cancer Center and Dragonfly Therapeutics announce strategic collaboration to take new immunotherapy candidates into clinical trials
15 Jan 2019 Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases
15 Jan 2019 Bio-Thera Solutions Ltd Partners with Cipla Ltd to Market Key Cancer Biosimilar
15 Jan 2019 Biomunex Pharmaceuticals signs a licensing agreement with Sanofi for the development of bi- and multi-specific antibodies
10 Jan 2019 SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System
10 Jan 2019 Elevian and Insilico Enter a Research Collaboration to Discover Drugs That Target Aging
10 Jan 2019 Daiichi Sankyo, Mitsubishi UFJ Capital and Tokyo Institute of Technology Announce Open Innovation Research on iPS Cell-derived Insulin Producing Cells in Japan
09 Jan 2019 Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices
08 Jan 2019 Gilead Sciences and Yuhan Corporation Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
07 Jan 2019 bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies
07 Jan 2019 Integral Molecular Enters Immuno-Oncology Target Discovery Collaboration with Daiichi Sankyo
07 Jan 2019 3SBio and Samsung Bioepis enter biosimilar collaboration agreement
07 Jan 2019 Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up